2017 Volume 149 Pages 128-132
We reviewed data on 273 patients with sudden deafness who visited our hospital between 2004 and 2008. All the patients received tapering courses of hydrocortisone with an initial dose of either 500 mg or 300 mg. The mean age was 51.2 years. Forty-one patients (15.0%) had diabetes mellitus (DM). In the <60 years of age group, the initial grade of deafness was significantly higher for the patients with DM than for those without DM. In the >60 years of age group, no significant differences in the initial grade of deafness were seen between patients with and those without DM. In the <60 years of age group, the treatment efficacy rate was significantly lower for the patients with DM than for the patients without DM. In the >60 years of age group, no significant differences in treatment efficacy were seen between patients with and those without DM. Thus, a correlation between DM and sudden deafness was seen for patients <60 years of age.
